An observational study in Ventricular Tachycardia, sponsored by CorVita Science Foundation. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-12.
Sponsored by CorVita Science Foundation · Observational
Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.
After consent from a patient the research team will input patients data from many different categories. There is a link to the PDF for the consent form, a patients anticoagulant medications will be assessed, their ventricular tachycardia (VT) history will be inputted, and their date of birth and zip code will inputted. The research team will then input any EKG's, echocardiograms, VT ablations, ICD's, S-ICD's, lab results, and comorbidities.
623 studies on the registry are indexed under Tachycardia; 81 are open to participants now.
This study's planned enrollment of 130 is below the median of 149 across 208 observational studies indexed under Tachycardia.
Browse Tachycardia studies →CorVita Science Foundation is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients who have been diagnosed and have evidence of ventricular tachycardia and are over the age of 18. Every patient was presented with a consent form and was given a description of the study in a clinical setting.
Exclusion Criteria:
-
Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,
Procedure: Ventricular Tachycardia Ablation · Device: ICD Implant · Drug: Antiarrhythmic drug · Diagnostic Test: EKG · Diagnostic Test: Cardioversion · Diagnostic Test: Echocardiogram
This is a surgical ablation meant to reset patients irregular rhythm back to sinus.
A pacemaker or defibrillator implant to prevent SCD
Also known as: Pacemaker Implant
Drug therapies
Also known as: Statin Therapy, Anticoagulants
Monitoring EKG testing done on registry patients
Monitoring cardioversions on registry patients
Monitoring echocardiogram testing done on patients
Recurrence of Ventricular Tachycardia
The natural progression of v-tach will be assessed through medical record review
Time frame: July 20, 2020 - Present
Number of Participants with Risk of Sudden Cardiac Death
All events of sudden cardiac death that arise from patients with ventricular tachycardia
Time frame: July 20, 2020 - Present
Prevent Risk of Stroke
All strokes, transient ischemic and systemic thrombo-embolic events
Time frame: July 20, 2020 - Present
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
CorVita Science Foundation